Global Veterinary Care Market (2021 to 2028)

Dublin, Jan. 20, 2022 (GLOBE NEWSWIRE) — The “Global Veterinary Care Market Size, Share & Trends Analysis Report by Care Type (Regular, Critical), by Animal Type (Companion, Production), by Region (North America, APAC ) and Segment Forecast, 2021-2028″ report has been added to from ResearchAndMarkets.com offer.

The global veterinary care market size is expected to reach USD 114.4 billion by 2028, registering a CAGR of 5.4% over the forecast period. The growing number of government initiatives aimed at safeguarding food safety is likely to drive the adoption of better veterinary care around the world. A significant rise in the adoption and humanization of pets globally is primarily responsible for the high need for veterinary care, which is driving the growth of the market.

Additionally, the COVID-19 pandemic has led to an increase in pet adoption. In June 2020, at the Society for the Prevention of Cruelty to Animals Los Angeles, pet adoptions were double their normal rate, with nearly 10 or 13 adoptions per day. Also, a waiting list had formed for certain types of canines and puppies, as there were so few left. Increased awareness among pet owners for regular checkups of their pets is further boosting the market.

The demand for animal protein is increasing worldwide due to rising per capita income. According to the OECD-FAO Agricultural Outlook 2020-2029 article, growth in meat consumption over the next decade is expected to increase by 12% by 2029. As demand for meat continues to increase increase, the demand for veterinary care is expected to increase rapidly. Key companies in the market are collaborating with animal welfare organizations to encourage awareness and advance veterinary healthcare, which further enhances the growth of the market.

Highlights of the Veterinary Care Market Report

  • Companion animals held the dominant share in the animal type segment owing to rising pet healthcare expenditures and rise in pet adoption

  • The food producing animal segment is expected to register the fastest CAGR during the forecast period owing to the increase in government initiatives aimed at improving the health of livestock

  • Additionally, increasing domestic beef production, consumption and exports are driving the growth of the segment

  • Regular care type for both production and companion animals dominated the global market in 2020 owing to increase in the number of pet owners, government initiatives to prevent various animal diseases and a large number of hospitals and veterinary clinics

Main topics covered:

Chapter 1. Methodology and scope

Chapter 2. Executive Summary

Chapter 3. Market Variables, Trends and Scope
3.1. Market Line Prospects
3.1.1. Parent Market Outlook
3.1.2. Related/auxiliary market outlook
3.2. Mapping of penetration and growth prospects
3.3. Dynamics of the veterinary care market
3.3.1. Market Driver Analysis
3.3.2. Market Restriction Analysis
3.3.3. Analysis of market opportunities
3.3.4. Analysis of market challenges
3.4. Veterinary Care Industry Analysis – Porter’s
3.4.1. Supplier Power
3.4.2. purchasing power
3.4.3. Surrogate Threat
3.4.4. The threat of new entrants
3.4.5. Competitive Rivalry
3.5. Veterinary Care Industry Analysis – PEST
3.5.1. Political and legal landscape
3.5.2. Economic Landscape
3.5.3. Social landscape
3.5.4. Technological landscape
3.6. Regulatory framework

Chapter 4. Impact of COVID-19 on the Veterinary Care Market
4.1. Disease prevalence analysis
4.2. Impact of Covid-19 and future scenario
4.3. Regulatory changes due to Covid-19
4.3.1. Strategies implemented by companies

Chapter 5. Veterinary Care Market: Animal Type Estimates and Trend Analysis
5.1. Animal Type Movement Analysis and Market Share, 2020 & 2028
5.2. Market size and forecast and trend analysis, 2016 to 2028 for the following:
5.2.1. Pet
5.2.1.1 Dogs
5.2.1.2 Cats
5.2.1.3 Equine
5.2.1.4 Others
5.2.2. Production animals

Chapter 6. Veterinary Care Market: Type of Care Estimates and Trend Analysis
6.1. Analysis of type of care movements and market share, 2020 and 2028
6.2. Market size and forecast and trend analysis, 2016 to 2028 for the following:
6.2.1 Pet
6.2.1.1 Regular
6.2.1.2. Emergency
6.2.1.3. Critical
6.2.1.4. Specialized services
6.2.2 Livestock
6.2.2.1 Regular
6.2.2.2. Emergency
6.2.2.3. Critical
6.2.2.4. Specialized services

Chapter 7. Veterinary Care Market: Regional Estimates and Trend Analysis
7.1. Regional movement analysis and market share, 2020 and 2028
7.2. Market share analysis, by region (North America, Europe, Rest of the world)
7.3. Market size and forecast and trend analysis, 2016 to 2028 for the following:
7.3.1. North America
7.3.1.1. we
7.3.1.2. Canada
7.3.2. Europe
7.3.2.1. UK
7.3.2.2. Germany
7.3.2.3. France
7.3.2.4. Italy
7.3.2.5. Spain
7.3.3. Asia Pacific
7.3.3.1. Japan
7.3.3.2. China
7.3.3.3. India
7.3.4. Latin America
7.3.4.1. Brazil
7.3.4.2. Mexico
7.3.5. Middle East and Africa
7.3.5.1. South Africa

Chapter 8. Competitive Analysis
8.1. Categorization of Market Participation
8.2. Competitive Dashboard Analysis
8.3. Public enterprises
8.3.1. Company Market Share / Position Analysis
8.3.2. Heat map analysis
8.4. Private companies
8.4.1. List of key companies

Chapter 9. Competitive Landscape
9.1. Company Profiles
9.1.1. Merck Animal Health
9.1.1.1. Company presentation
9.1.1.2. Financial performance
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic initiatives
9.1.2. Ceva Animal Health
9.1.2.1. Company presentation
9.1.2.2. Financial performance
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic initiatives
9.1.3. Zoetis
9.1.3.1. Company presentation
9.1.3.2. Financial performance
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic initiatives
9.1.4. Boehringer Ingelheim GmbH
9.1.4.1. Company presentation
9.1.4.2. Financial performance
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic initiatives
9.1.5. Elanco
9.1.5.1. Company presentation
9.1.5.2. Financial performance
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic initiatives
9.1.6. IDEXX Laboratories, Inc.
9.1.6.1. Company presentation
9.1.6.2. Financial performance
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic initiatives
9.1.7. Heska Company
9.1.7.1. Company presentation
9.1.7.2. Financial performance
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic initiatives
9.1.8. Virbac
9.1.8.1. Company presentation
9.1.8.2. Financial performance
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic initiatives
9.1.9. Vetoquinol SA
9.1.9.1. Company presentation
9.1.9.2. Financial performance
9.1.9.3. Product Benchmarking
9.1.9.4. Strategic initiatives
9.1.10. Indian Immunologicals Ltd.
9.1.10.1. Company presentation
9.1.10.2. Financial performance
9.1.10.3. Product Benchmarking
9.1.10.4. Strategic initiatives

For more information on this report, visit https://www.researchandmarkets.com/r/jzue7u

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Comments are closed.